ArticleMolecular imaging and radionuclide therapy2024
Quantitative Performance Evaluation of Commonly Used Colormaps for Image Display in Myocardial Perfusion Imaging: Analysis based on Perceptual Metrics.
Article in Molecular imaging and radionuclide therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Colour maps for representation of quantitative metrics in radiology: meaningful or misleading?Insights into imaging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To quantitatively evaluate the performance of the most used colormaps in image display using perceptual metrics and to what extent these measures are congruent with the true intensity or uptake of pixels at different levels of defect severity in simulated cardiac images. Methods: Six colormaps, labeled "Gray", "Thermal", "Cool", "CEqual", "Siemens" and "S Pet" extracted from FIJI ImageJ software are included. Colormap data are converted from the red, green, blue color space to CIELAB. Perceptual metrics for measuring "color difference" were calculated, including difference (ΔE Results: In 0% defect, all the curves are at the highest level, except for "s pet", in that the lightness is not at its maximum value. In the phantom with 10% defect (or 90% of maximum value), discrepancies among curves appear. In "Siemens", the ΔE Conclusion: Of 6 colormaps investigated for estimating defect severity, "grayscale" is less favorable than others and "thermal" performs slightly better. "S pet" or rainbow, which is used traditionally by many practitioners, is strongly discouraged. The "Siemens" colormap suffers from decreased discriminating power in the range of mild to moderate/severe. In contrast, the "cool" and "cequal" colormaps outperform the other colormaps employed in this study to some extent, although they have some shortcomings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.